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Abstract: The aim of this study was to analyze the concurrent validity, test–retest reliability,
and capacity to detect changes of four different portable devices used to measure a wide range
of neuromuscular parameters derived from countermovement jump (CMJ). An accelerometric
device (Myotest), a jump mat (Ergojump), an optical device (Optojump), and a smartphone app
(MyJump) were simultaneously examined for concurrent validity against gold-standard measures
(motion-capture system and a force platform). Twenty-two CMJ-derived variables were collected
from 15 healthy male subjects (n = 60 CMJs). Contraction time (CT) and eccentric duration (EccD)
measurements obtained from the Myotest were moderately to largely associated with and not
different from force platform measurements (r = 0.31 to 0.64, ES = 0.11 to 0.18) and showed moderate
test-retest reliability (intraclass correlation coefficient (ICC) = 0.92 to 0.97, coefficient of variation
(CV) = 3.8 to 8.0%). Flight time (FT) and jump height (JH) from Ergojump, Optojump, and MyJump
showed moderate to strong associations with gold-standard measurements (r = 0.57 to 0.98) and good
test–retest reliability (ICC = 0.54 to 0.97, CV = 1.8 to 4.2). However, all portable devices underestimated
JH (ES = 1.25 to 2.75). Independent of the instrument used, the analyzed CMJ variables showed good
capacity to detect changes (standard error of measurement (SEM) < smallest worthwhile change
(SWC)), with the exception of rate of force and rate of power development parameters, which showed
marginal capacity (SEM > SWC). The Myotest is preferable to measure temporal parameters during
ground contact, whereas Ergojump, Optojump, and MyJump devices may be preferable to measure
FT and JH, with the Optojump being the most accurate.
Keywords: force platform; motion analysis; neuromuscular assessment; measurements;
reliability; validity
1. Introduction
The countermovement jump (CMJ) is one of the most popular tests to monitor an athlete’s muscle
power of the lower extremities. An athlete’s CMJ performance is relevant in a variety of sports
and commonly quantified by jump height (JH) or flight time (FT), which have been considered
as indicators of vertical jump performance [1,2] and used to measure training adaptations and
monitor neuromuscular fatigue [3]. However, CMJ execution is dependent on various time and
force components throughout the various phases preceding the flight [4]. Therefore, the use of JH or
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FT in isolation as a global indicator of muscle power in the lower extremities does not inform about
the specific contribution of neuromuscular components during ground contact, consequently masking
training-induced adaptations or neuromuscular fatigue.
CMJ performance variables have been adopted to describe chronic neuromuscular adaptations and
acute neuromuscular fatigue in response to exercise, but contradictory results have been observed. Silva
et al. [2] examined the correlation between individual match exposure and changes in JH in professional
athletes throughout an entire season, reporting no significant training-induced effects. On the other
hand, reports in young athletes showed negative associations between various training load parameters
(e.g., session rating of perceived exertion exposure time to training) and changes in JH [5]. In addition,
JH significantly dropped in response to recreational 5v5 small-sided soccer games [6], whereas CMJ
height was not altered following 4v4 and 8v8 small-sided soccer games [7]. Taken together, these
findings indicate that JH or FT per se does not elucidate an eventual mask over acute fatigue responses
or over chronic adaptations to exercise. In this context, critical information can be directly extracted
from the force–time curves during the CMJ, and various parameters (e.g., contraction duration, time to
peak force/power) have been recently deemed suitable for neuromuscular fatigue detection. Regarding
neuromuscular adaptations, variations in force–time parameters (e.g., flight time to contraction time
ratio) were observed in Australian football players over the course of a season, indicating sensitivity to
increases with training load over time [8]. Moreover, during a six-week training block with progressive
increases in training load, subjective wellness was positively associated with changes in maximum rate
of force development, force at zero velocity, and FT (r = 0.28–0.34) in female rugby players [9].
In laboratory conditions, CMJ time and force components may be accurately assessed, providing
valid and reliable results using a force platform (FP) [10,11] or video-based motion capture system
(MCAP) [1]. For instance, Gathercole et al. [12] examined the reliability and fatigue sensitivity of the
CMJ test using an FP, reporting a meaningful reduction in 18 neuromuscular variables obtained from
CMJ after a high-intensity fatiguing protocol. These findings suggest that acute fatigue can induce a
decrease of peak force and eccentric function and an increase of jump duration [10]. Although FP and
MCAP are considered gold standards for CMJ measurement, limited access and associated costs make
them unsuitable, especially for field-based testing. Therefore, it would be of interest to understand
whether portable equipment frequently used in CMJ testing would allow the assessment of valid and
reliable time and force components of CMJ. For example, the Myotest device uses a body accelerometer
and has been shown to be a valid and reliable method for the assessment of JH [13,14]. Moreover, the
traditional switch mat consists of a digital apparatus connected by a cable to a resistive platform, and
can be used on flat surface to test CMJ [15]. Optical systems have been proposed to determine JH by
measuring FT [16]. Even more recently, promising results were found from an iPhone app (MyJump),
showing excellent validity in relation to FP to measure JH based on the flight-time method [17].
No studies have attempted to simultaneously analyze the suitability of a wide range of portable
equipment to characterize athletes’ neuromuscular performance. The purpose of this study was to
analyze the concurrent validity, test–retest reliability, and capacity to detect changes of four different
portable devices used to measure a wide range of CMJ-derived neuromuscular parameters.
2. Materials and Methods
2.1. Subjects
Fifteen male undergraduate sports sciences students with an average age of 27.0 ± 5.0 years,
height of 174.0 ± 9.0 cm, body mass of 72.2 ± 8.28 kg, and training hours of 5.0 ± 2.0 h per week
were tested in January 2018. They were regularly involved in various activities such as weight
lifting, resistance training, and recreational team sports, and had been injury-free during the last
2 years. All volunteers agreed to provide their maximum effort during all laboratory tests, and they
were formally and verbally informed that they were free to withdraw from the study without any
Sports 2018, 6, 91 3 of 15
consequences. The ethical board of the Faculty of Sports, University of Porto approved and recorded
the study under CEFADE.08.2018.
2.2. Experimental Design
Four portable devices were examined against the gold standard (FP and MCAP) using 5 CMJs [15]
performed by each participant. Each CMJ for each piece of equipment was entered in the database as a
single case for intratrial assessment. This methodological approach was used to eliminate the intertrial
variability provided by single jump condition performance (i.e., comparisons between independent
jump conditions) [13,18]. The independent variable was the device, whereas 22 CMJ-derived
parameters, listed in Table 1, were set as the dependent variables.
Table 1. Definitions of neuromuscular parameters adopted.
Variables Abbreviation Unit of Measure Definition
Kinematic parameters - - -
Total contraction time CT s Total duration from jump initiation to take-off
Eccentric duration EccD s Time period of the eccentric phase
Concentric duration ConD s Time period of the concentric phase
Time to peak force T2PF s Time period between jump start and peak force
Time to peak power T2PP s Time period between jump start and peak power
Flight time FT s Time period of zero force, corresponding to noncontact with the floor
Flight time to contraction
time ratio FT:CT % Ratio between flight time and contraction time
Peak velocity PV m·s−1 Highest jump velocity during the concentric phase
Minimum velocity MinV m·s−1 Lowest jump velocity during the eccentric phase
Velocity at peak power V@PP m·s−1 Velocity recorded at time point where peak power occurred
Jump height JH m Highest height achieved during the jump
Kinetic parameters - - -
Peak force PF N·kg−1 Maximum force achieved during the concentric phase
Mean force MF - Average force of the concentric phase
Maximum rate of eccentric
force development mREFD N·s




mRCFD N·s−1·kg−1 Maximum force increase within a 30 ms window during theconcentric phase.
Force at zero velocity F@0V N·kg−1 Force exerted at the end of the countermovement where the jumptransitions from eccentric to concentric movement
Peak power PP W·kg−1 Higher power value achieved during the jump
Mean power MP W·kg−1 Average power value obtained during the concentric phase
Maximum rate of power
development mRPD W·s




MEccConP W·kg−1·s−1 Power produced during both eccentric (converted to positive values)and concentric phases, divided by contraction duration
Total impulse TI N·s−1 Force exerted concentrically multiplied by the time takenconcentrically
Relative net impulse RNI N·s·kg−1
Impulse between the beginning of the concentric phase and the
moment force reached weight level, minus the impulse equivalent to
that of the propulsion-deceleration phase
Despite the various vertical jump protocols that have been proposed [7,14], CMJ has been
considered the most popular and easiest to perform [13]. The subjects received instructions about how
to correctly perform CMJ in a separate familiarization session 24 h before data collection. On the data
collection day, each subject performed a 5 min cycling warmup on a stationary bike and 2 preliminary
CMJs. Then, equipped with an accelerometric system, they were positioned in an upright stance with
their feet shoulder-width apart and their toes pointed forward or slightly outward, on the center of
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the FP, on a switch mat, within optical equipment with light-emitting diodes (LEDs), and in front of a
smartphone, simultaneously. The participants executed the jump by flexing their knees to a position
they perceived to be comfortable (i.e., preferred starting push-off position) [11,19]. To limit possible
variations in posture during the jump that could affect the final assessment, the no-arm swing version
was used [13]. At least 30 s recovery was allowed between jump trials.
Eleven kinematic parameters suggested by Gathercole et al. [12] and 11 kinetic parameters
previously described elsewhere [4,12,20] were considered (Table 1). All kinetic parameters were scaled
to the subject’s body mass.
2.3. Procedures
2.3.1. Gold-Standard Measurements
A motion capture system (Qualisys AB, Göteborg, Sweden) operating at a 200 Hz sampling
frequency was used. Because CMJ is mainly executed in the sagittal plane, a marker was attached
to the left lateral femoral condyle to avoid recording displacement in the frontal plane associated
with trunk flexion. This also allowed the mark to be placed as close to the center of mass as possible,
enabling tracking along all CMJ phases [19]. This system is capable of ignoring other movement,
considering only vertical displacement. The marker displacement, peak, and minimum velocity from
the starting position to peak JH were quantified. Second, an extensiometric FP (Bertec FP9060, Bertec,
Columbus, KY, USA) embedded in the floor, with a sampling frequency of 2000 Hz, was used. Motion
capture and FP data were simultaneously collected using Qualisys Track Manager software (Qualisys
AB, Göteborg, Sweden). Force platform variables were computed from the force-velocity, -time, and
-acceleration traces using a custom-made MATLAB routine (MATLAB, MathWorks, Natick, MA, USA).
According to a specific variable, only 1 criterion (MCAP or FP) was chosen as gold standard.
2.3.2. Accelerometric System
The Myotest Pro (Myotest, Sion, Switzerland) uses a 3-dimensional accelerometer inserted into a
small box (dimensions 5.5 × 8.5 × 2.3 cm, mass 50 g) that is secured at waist level with a purpose-built
strap (Velcro belt) with an elastic waistband. The Myotest measures acceleration on the vertical axis of
the load, on which the accelerometer sensor is fixed, using a sampling rate of 200 Hz. The device was
perpendicularly attached to a large (8.5 cm) Velcro elastic belt provided with the device. This was fixed
to hip level on the left side of the body, as indicated by the manufacturer, and attached to the left lateral
femoral head to reduce the possible accelerations induced by trunk flexion (during the eccentric phase)
and extension (i.e., propulsion), thus emphasizing vertical displacement. Accelerometry data were
stored during the assessments and subsequently downloaded using the proprietary software (Myotest
PRO Software version 1.0, Myotest, Sion, Switzerland), and further neuromuscular variables were
computed from raw data of acceleration over time, using a custom-made MATLAB routine (MATLAB,
MathWorks, Natick, MA, USA). For the accelerometric system, JH was computed using the flight-time
method [10].
2.3.3. Switch Mat
The Ergojump mat recorded FT from take-off to landing. The switch mat was placed on top of the
floor-embedded force platform and the mat’s weight was removed from the force platform data. This
equipment provides JH and FT immediately following the jump. Furthermore, peak power was also
calculated using the Sayers equation [21] as follows:
Peak power (W) = 61.9 × JH (cm) + 36.0 × subject’s body mass (kg) + 1.822 (1)
2.3.4. Optical Equipment with Light-Emitting Diodes
The Optojump system (Optojump, Microgate, Bolzano, Italy) consists of 2 bars (transmitting and
receiving bars, 1 m apart) equipped with 33 optical LEDs fitted in the transmitting bar that continuously
Sports 2018, 6, 91 5 of 15
communicate with the corresponding set in the receiving bar. The LEDs are positioned 0.3 cm from
ground level, on the Ergojump mat, and at 3.125 cm intervals. Any break of the beam switched on and
off automatically activates a digital chronometer used to calculate FT and JH [10].
2.3.5. Smartphone App
The MyJump app was installed on an iPhone 6, which includes a 120 Hz high-speed camera, at a
quality of 720 p. MyJump was designed to calculate the time (in ms) between 2 frames selected by the
user and subsequently JH using the following equation:
JH = FT2 × 1.22625 (2)
A researcher lay prone on the ground with the iPhone 6 facing the participant (in the frontal plane)
~1.5 m from the force platform at floor level, and zoomed in on the feet of the participant. The MyJump
app provides JH, FT, and peak velocity. Peak power was also computed as previously described.
2.4. Statistical Analysis
In accordance with the outlier removal procedure suggested by Gathercole et al. [12], we selected
the 4 out of 5 most consistent CMJ repetitions (differing least from the mean) based on mean eccentric
and concentric power over time. Therefore, only 4 CMJs collected were considered for analysis,
resulting in 60 cases across the 75 jumps performed. All variables were normally distributed, and data
are reported as mean ± standard deviation (SD).
Correlations between the gold standard and portable devices were quantified using the following
criteria: ≤0.1 (trivial), 0.1–0.3 (small), 0.3–0.5 (moderate), 0.5–0.7 (large), 0.7–0.9 (very large), and
≥0.9 (almost perfect). Substantial over- and underestimations were analyzed using paired sample
t-test. Differences were interpreted using effect size (ES) according to Hopkins [22] as trivial (<0.2),
small (0.2–0.6), moderate (0.6–1.2), large (1.2–2.0), very large (2.0–4.0), and huge (>4.0). When 90%
confidence intervals (CIs) overlapped positive and negative values, the effect was deemed as unclear.
Otherwise, the magnitude is reported as the observed value. A large correlation (r ≥ 0.90) and a
trivial difference (ES < 0.2) indicated sufficient validity. Test–retest reliability was assessed using
intraclass correlation coefficient (ICC) (absolute reliability [1,2], a 2-way random effects model with
single measure) and coefficients of variation (CV; relative reliability). For ICC, we used criteria
suggested by Portney and Watkins [23] to evaluate reliability as follows: ≥0.75 (good), 0.50–0.74
(moderate), 0.26–0.50 (fair), and ≤0.25 (poor). CV was calculated by dividing the within-subjects SD
by the mean and then multiplying by 100, qualitatively classified as good (<5%), moderate (5–10%),
and poor (>10%). ICC ≥ 0.75 and CV ≤ 10% were defined as sufficient reliability. Standard error of
measurement (SEM) was calculated by dividing the SD of the difference score between test and retest
by
√
ICC [24]. The smallest worthwhile change (SWC) was determined to establish the usefulness of
the test by multiplying the between-subject standard deviation by 0.2. If SEM is smaller than SWC, the
ability to detect a change is “good”; if SEM equals SWC, then the test is “satisfactory”; but if SEM is
greater than SWC, then the test is rated as “marginal” [25]. The minimal detectable change (MDC95)
was calculated as MDC95 = SEM ×
√
2 × 1.96 [25].
3. Results
Descriptive values are reported in Table 2. Differences and correlations between gold standard
and portable devices are reported in Figures 1 and 2, respectively.
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Table 2. Descriptive values of countermovement jump (CMJ) kinematic variables obtained with
different devices. Values are mean ± standard deviation (SD).
Variable MCAP Force Platform Myotest Ergojump Optojump MyJump
Kinematic parameters
CT (s) - 0.77 ± 0.16 0.76 ± 0.09 - - -
EccD (s) - 0.50 ± 0.15 0.50 ± 0.08 - - -
ConD (s) - 0.26 ± 0.02 0.26 ± 0.04 - - -
T2PF (s) - 0.55 ± 0.17 0.60 ± 0.10 - - -
T2PP (s) - 0.71 ± 0.16 0.67 ± 0.09 - - -
FT (s) - 0.54 ± 0.03 0.49 ± 0.04 0.55 ± 0.06 0.53 ± 0.03 0.57 ± 0.03
Table 2. Cont.
Variable MCAP Force Platform Myotest Ergojump Optojump MyJump
FT:CT (%) - 0.72 ± 0.16 0.66 ± 0.10 - - -
PV (m·s−1) 3.04 ± 0.23 - 2.08 ± 0.39 - - 1.42 ± 0.23
MinV (m·s−1) −1.25 ± 0.16 - −1.08 ± 0.26 - - -
V@PP (m·s−1) - 2.47 ± 0.15 1.89 ± 0.34 - - -
JH (m) 0.46 ± 0.04 - 0.42 ± 0.04 0.38 ± 0.07 0.35 ± 0.04 0.41 ± 0.04
Kinetic parameters
PF (N·kg−1) - 23.88 ± 1.99 22.23 ± 2.37 - - -
MF (N·kg−1) - 13.39 ± 1.24 11.96 ± 0.82 - - -
mREFD (N·s−1·kg−1) - 136.88 ± 69.88 101.27 ± 36.22 - - -
mRCFD (N·s−1·kg−1) - 29.37 ± 19.93 57.44 ± 23.82 - - -
F@0V (N·kg−1) - 23.16 ± 2.31 18.77 ± 3.30 - - -
PP (W·kg−1) - 36.01 ± 8.80 47.84 ± 10.17 46.18 ± 5.38 51.47 ± 3.80 -
MP (W·kg−1) - 28.66 ± 2.51 18.89 ± 5.17 - - -
mRPD (W·s−1·kg−1) - 345.49 ± 81.79 301.08 ± 84.41 - - -
MEccConP (W·kg−1·s−1) - 13.63 ± 2.29 9.14 ± 2.04 - - -
TI (N·s−1) - 197.00 ± 29.77 121.74 ± 47.34 - - -
RNI (N·s−1·kg−1) - 2.61 ± 0.16 1.70 ± 0.40 - - -
MCAP, motion capture system; ConD, concentric duration; CT, total contraction time; EccD, eccentric duration;
F@0V, force at zero velocity; FT, flight time; FT:CT, flight time to contraction time ratio; MP, mean power; MEccConP,
mean eccentric and concentric power over time; MinV, minimum velocity; mRCFD, maximum rate of concentric
force development; mRCED, maximum rate of eccentric force development; mRPD, maximum rate of power
development; PF, peak force; PP, peak power; PV, peak velocity; RNI, relative net impulse; T2PF, time to peak force;
T2PP, time to peak power; TI, total impulse; V@PP, velocity at peak power.
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Figure 1. Differences between gold-standard measurements and four portable devices in
22 neuromuscular parameters. Shaded area indicates trivial differences (ES < 0.2). ConD, concentric
duration; CT, total contraction time; EccD, Eeccentric duration; ES, effect size; F@0V, force at zero
velocity; FT, flight time; FT:CT, flight time to contraction time ratio; ICC, intraclass correlation coefficient;
MF, mean force; MP, mean power; MEccConP, mean eccentric and concentric power over time; MinV,
minimum velocity; mRCFD, maximum rate of concentric force development; mREFD, aximum rate
of eccentric force development; mRPD, maximum rate of power development; PF, peak force; PP, peak
power; PV, peak velocity; RNI, relative net impulse; T2PF, time to f rc ; T2PP, time to peak power;
TI, total impulse; V@PP, velocity at peak power. Gold standard is a motion capture system for PV,
MinV, and JH, and force platform for all remaining variables.
CT, EccD, concentric duration (ConD), and peak force (PF) obtained from the Myotest were
moderately to largely correlated and not significantly different from FP measurements (r = 0.31–0.64,
ES = 0.11–0.18). In addition, FT, JH, PF, maximum rate of eccentric force (mREFD), maximum rate
of concentric force development (mRCFD), force at zero velocity (F@0V), maximum rate of power
development (mRPD), and time to peak power (TI) measurements were positively correlated with but
underestimated FP measurements (r = 0.44–0.71, ES = 0.53–2.20). The remaining variables were not
valid when compared to gold-standard measurements. FT obtained from Ergojump was positively
correlated with and not different from FP (r = 0.61 [0.09; 0.32], ES = 0.21 [−0.55; 0.14]). In contrast,
JH was strongly associated with but substantially different from FP (r = 0.69; ES = 1.40 [1.00; 1.79]).
FT obtained from Optojump was valid in relation to FP (r = 0.98 [0.97; 0.99], ES = 0.33 [−0.01; 0.68]).
Despite JH from Optojump being almost perfectly correlated with these devices, they were significantly
different (r = 0.90; ES = 2.75 [2.23; 3.23]). FT and JH obtained from MyJump were strongly associated
with FP and MCAP (r = 0.67 [0.54; 0.67] and 0.66 [0.53; 0.76], respectively). However, FT overestimated
FP, and JH underestimated MCAP measurements (ES = −0.1.00 [−1.36; −0.63] and 1.25 [0.85; 1.63],
respectively). Estimated PP obtained from MyJump was largely associated with and not different from
PP from MCAP (r = 0.61 [0.46; 0.72]; ES = −0.15 [−0.49; −0.20]). A huge underestimation was found
for MyJump-derived PV compared to MCAP (ES = 9.65 [8.05; 11.06]). Estimated PP assessed via all
devices was not valid in relation to FP measurements.
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Figure 2. Correlations between gold standard measurements and four portable devices in
22 neuromuscular parameters. Filled gray area indicates no significant correlation (r < 0.1). Shaded
space indicates almost perfect correlation (r ≥ 0.9). ConD, concentric duration; CT, total contraction
time; EccD, eccentric duration; ES, effect size; F@0V, force at zero velocity; FT, flight time; FT:CT,
flight time to contraction time ratio; ICC, intraclass correlation coefficient; MF, mean force; MP, mean
power; MEccConP, mean eccentric and concentric power over time; MinV, minimum velocity; mRCFD,
maximum rate of concentric force development; mREFD, maximum rate of eccentric force development;
mRPD, maximum rate of power development; PF, peak force; PP, peak power; PV, peak velocity; RNI,
relative net impulse; T2PF, time to peak force; T2PP, time to peak power; TI, otal impulse; @PP,
velocity at peak power. Gold standard s a motion capture system for PV, MinV, and JH, and force
platform for all remaining variables.
A detailed description of test–retest reliability is reported in Table 3. FT and JH were reliable for
all portable devices (ICC = 0.54–0.97, CV = 1.8–4.2%). CT, EccD, time to peak force (T2PF), time to
peak power (T2PP), flight time to contraction time ratio (FT:CT), PF, MF, F@0V, and mean eccentric and
concentric power over time (MEccConP) obtained from Myotest showed good absolute and relative
reliability (ICC = 0.89–0.97, CV = 3.8–9.5%). PV obtained from MyJump also showed good t st–retest
reliability (ICC [95% CI] = 0.97 [0.91; 0.99]; CV = 3.9%). With the exception of Myotest, PP was reliable for
all portable devices (ICC = 0.84–0.91, CV = 3.3–4.5%). In all devices, all variables showed goo capacity
to detect changes (SEM < SWC), except for mREFD, mRCFD, and mRPD (SEM > SWC) (Table 4).
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Table 3. Test–retest reliability of CMJ kinematic variables obtained with two gold-standard pieces of equipment and four portable devices.
Variable ReliabilityIndicators MCAP Force Platform Myotest Ergojump Optojump MyJump
CT
ICC (95% CI) - 0.84 (0.58; 0.95) 0.93 (0.83; 0.98) - - -
CV (%) - 120.1 (7.7; 16.5) 6.8 (4.9; 8.7) - - -
EccD
ICC (95% CI) - 0.81 (0.51; 0.94) 0.95 (0.87; 0.98) - - -
CV (%) - 17.5 (10.1; 24.9) 8.0 (5.7; 10.3) - - -
ConD
ICC (95% CI) - 0.89 (0.71; 0.96) 0.72 (0.27; 0.92) - - -
CV (%) - 6.8 (5.2; 8.3) 12.0 (7.1; 16.9) - - -
T2PF
ICC (95% CI) - 0.80 (0.48; 0.94) 0.93 (0.82; 0.98) - - -
CV (%) - 21.1 (14.4; 27.7) 7.9 (5.8; 10.1) - - -
T2PP
ICC (95% CI) - 0.82 (0.52; 0.95) 0.93 (0.83; 0.98) - - -
CV (%) - 13.3 (8.6; 18.1) 7.0 (5.1; 8.9) - - -
FT
ICC (95% CI) - 0.97 (0.92; 0.99) 0.96 (0.91; 0.99) 0.54 (−0.34; 0.89) 0.96 (0.91; 0.99) 0.80 (0.37; 0.96)
CV (%) - 1.8 (1.3; 2.2) 3.8 (0.4; 7.2) 8.2 (0.8; 15.7) 1.8 (1.4; 2.3) 3.0 (2.1; 3.8)
FT:CT
ICC (95% CI) - 0.73 (0.30; 0.92) 0.92 (0.78; 0.98) - - -
CV (%) - 13.2 (8.0; 18.3) 8.4 (3.4; 13.4) - - -
PV
ICC (95% CI) 0.91 (0.78; 0.97) - 0.78 (0.44; 0.94) - - 0.74 (0.17; 0.95)
CV (%) 5.2 (3.2; 7.1) - 11.6 (7.6; 15.3) - - 3.3 (2.2; 4.4)
MinV
ICC (95% CI) 0.79 (−39; 0.95) - 0.50 (−0.30; 0.86) - - -
CV (%) −6.8 (−8.0; −5.6) - −18.0 (−24.6; −12.3) - - -
V@PP
ICC (95% CI) - 0.97 (0.92; 0.99) 0.79 (0.46; 0.94) - - -
CV (%) - 2.1 (1.54; 2.6) 11.1 (7.7; 14.5) - - -
JH
ICC (95% CI) 0.96 (0.90; 0.99) - 0.97 (0.92; 0.99) 0.93 (0.81; 0.98) 0.87 (0.62; 0.97) 0.97 (0.91; 0.99)
CV (%) 3.3 (2.2; 4.4) - 4.2 (3.2; 5.3) 3.2 (2.3; 4.1) 4.2 (3.3; 5.1) 3.9 (3.0; 4.9)
PF
ICC (95% CI) - 0.83 (0.57; 0.95) 0.91 (0.77; 0.97) - - -
CV (%) - 3.4 (2.4; 4.5) 6.4 (4.4; 8.3) - - -
MF
ICC (95% CI) - 0.89 (−0.73; 0.96) 0.89 (0.70; 0.96) - - -
CV (%) - 5.2 (1.9; 8.5) 4.2 (2.5; 5.9) - - -
mREFD
ICC (95% CI) - 0.89 (0.71; 0.97) 0.76 (0.37; 0.93) - - -
CV (%) - 17.1 (10.8; 23.4) 21.1 (15.3; 26.8) - - -
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Table 3. Cont.
Variable ReliabilityIndicators MCAP Force Platform Myotest Ergojump Optojump MyJump
mRCFD
ICC (95% CI) - 0.84 (0.62; 0.95) 0.28 (−0.29; 0.86) - - -
CV (%) - 46.4 (30.4; 62.4) 30.9 (20.9; 40.9) - - -
F@0V - - - - - -
F@0V
ICC (95% CI) - 0.90 (0.74; 0.97) 0.91 (0.77; 0.97) - - -
CV (%) - 4.3 (2.7; 5.9) 8.9 (5.6; 12.2) - - -
PP
ICC (95% CI) - 0.95 (0.87; 0.98) 0.81 (0.52; 0.94) 0.91 (0.79; 0.97) 0.86 (0.63; 0.96) 0.84 (0.48; 0.96)
CV (%) - 3.4 (2.1; 4.7) 15.8 (11.3; 20.4) 3.3 (2.3; 4.3) 4.5 (1.0; 8.1) 4.0 (3.0; 5.0)
MP
ICC (95% CI) - 0.91 (0.77; 0.97) 0.84 (0.59; 0.95) - - -
CV (%) - 3.8 (2.7; 5.0) 14.8 (10.2; 19.3) - - -
mRPD - - - - - -
mRPD
ICC (95% CI) - 0.75 (0.34; 0.93) 0.84 (0.58; 0.95) - - -
CV (%) - 10.1 (8.0; 12.3) 16.0 (10.6; 21.3) - - -
MEccCONP
ICC (95% CI) - 0.87 (0.65; 0.96) 0.93 (0.81; 0.98) - - -
CV (%) - 9.0 (5.9; 12.1) 9.5 (5.8; 13.2) - - -
TI
ICC (95% CI) - 0.79 (0.44; 0.94) 0.95 (0.87; 0.98) - - -
CV (%) - 5.6 (1.3; 9.9) 24.4 (10.8; 37.9) - - -
RNI
ICC (95% CI) - 0.97 (0.92; 0.99) 0.86 (0.63; 0.96) - - -
CV (%) - 1.7 (1.1; 2.2) 15.9 (10.1; 21.8) - - -
MCAP, motion capture system; ConD, concentric duration; CT, total contraction time; EccD, eccentric duration; F@0V, force at zero velocity; FT, flight time; FT:CT, flight time to contraction
time ratio; MP, mean power; MEccConP, mean eccentric and concentric power over time; MinV, minimum velocity; mRCFD, maximum rate of concentric force development; mRCED,
maximum rate of eccentric force development; mRPD, maximum rate of power development; PF, peak force; PP, peak power; PV, peak velocity; RNI, relative net impulse; T2PF, time to
peak force; T2PP, time to peak power; TI, total impulse; V@PP, velocity at peak power. Bold indicates reliable measurements (ICC > 0.75, CV < 10%).
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Table 4. Standard error of measurement, smallest worthwhile change, and minimum detectable change of jump variables obtained with different devices.
Variable MCAP Force Platform Myotest Ergojump Optojump MyJump
SEM SWC MDC SEM SWC MDC SEM SWC MDC SEM SWC MDC SEM SWC MDC SEM SWC MDC
Kinematic parameters
CT (s) - - - 0.02 0.03 0.05 0.012 0.018 0.033 - - - - - - - - -
EccD (s) - - - 0.01 0.03 0.05 0.010 0.016 0.029 - - - - - - - - -
ConD (s) - - - 0.003 0.006 0.01 0.005 0.008 0.015 - - - - - - - - -
T2PF (s) - - - 0.02 0.03 0.06 0.013 0.021 0.038 - - - - - - - - -
T2PP (s) - - - 0.02 0.03 0.06 0.011 0.018 0.033 - - - - - - - - -
FT (s) - - - 0.004 0.006 0.01 0.005 0.008 0.015 0.008 0.013 0.024 0.004 0.006 0.012 0.003 0.006 0.010
FT:CT (%) - - - 0.02 0.03 0.05 0.013 0.021 0.038 - - - - - - - -
PV (m·s−1) 0.04 0.06 0.11 - - - 0.050 0.078 0.14 - - - - - - - -
MinV (m·s−1) 0.02 0.03 0.05 - - - 0.032 0.050 0.090 - - - - - - - -
V@PP (m·s−1) - - - 0.02 0.03 0.05 0.04 0.06 0.056 - - - - - 0.009 0.015 0.027
JH (m) 0.005 0.008 0.015 - - - 0.005 0.008 0.014 0.010 0.015 0.028 0.005 0.009 0.016 0.005 0.008 0.015
Kinetic parameters
PF (N·kg−1) - - - 0.26 0.40 0.73 0.30 0.47 0.84 - - - - - - - - -
MF (N·kg−1) - - - 0.16 0.26 0.47 0.10 0.16 0.47 - - - - - - - - -
mREFD (N·s−1·kg−1) - - - 9.42 1.88 26.11 4.88 0.97 13.53 - - - - - - - - -
mRCFD (N·s−1·kg−1) - - - 2.74 0.54 7.59 3.46 0.69 9.61 - - - - - - - - -
F@0V (N·kg−1) - - - 0.30 0.47 0.84 0.42 0.65 1.17 - - - - - - - - -
PP (W·kg−1) - - - 0.63 0.98 1.76 1.13 1.76 3.15 1.31 2.03 3.63 0.69 1.07 1.92 0.49 0.76 1.36
MP (W·kg−1) - - - 0.32 0.51 0.91 0.67 1.03 1.86 - - - - - - - - -
mRPD (W·s−1) - - - 11.38 2.27 31.54 0.30 0.06 0.84 - - - - - - - - -
MEccConP
(W·kg−1·s−1) - - - 0.29 0.45 0.80 0.25 0.40 0.71 - - - - - - - - -
TI (N·s−1) - - - 4.06 6.29 11.26 6.24 9.67 17.30 - - - - - - - - -
RNI (N·s−1·kg−1) - - - 0.02 0.03 0.05 0.05 0.08 0.14 - - - - - - - - -
MCAP, motion capture system; ConD, concentric duration; CT, total contraction time; EccD, eccentric duration; F@0V, force at zero velocity; FT, flight time; FT:CT, flight time to contraction
time ratio; MCD, minimal detectable change; MF, mean force; MP, mean power; MEccConP, mean eccentric and concentric power over time; MEF, mean eccentric force; MinV, minimum
velocity; mRCFD, maximum rate of concentric force development; mRCED, maximum rate of eccentric force development; mRPD, maximum rate of power development; PF, peak force;
PP, peak power; PV, peak velocity; RNI, relative net impulse; SEM, standard error of measurement; SWC, smallest worthwhile change; T2PF, time to peak force; T2PP, time to peak power;
TI, total impulse; V@PP, velocity at peak power.
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4. Discussion
To best of our knowledge, this is the first study assessing the validity and reliability of different
portable devices to measure CMJ-derived parameters. Different instruments may be used in the field
according to the targeted neuromuscular parameter. Specifically, Myotest is valuable for measuring
CMJ-derived temporal parameters during ground contact (e.g., CT and EccD), whereas Ergojump,
Optojump, and MyJump may be preferable for measuring FT and JH. On the other hand, FT obtained
from Optojump was the only variable that was either valid (in relation to gold-standard devices) and
reliable (test–retest) to measure CMJ performance. FT should be used as the criterion measure of jump
performance instead of JH, since it is directly measured. Indeed, JH is indirectly obtained from an
equation that uses the flight time squared [10], which means that the measurement error increases
with longer flight times. It should also be noted that the equipment tested for reliability and validity
showed good sensitivity to detecting changes in all variables measured, with the exception of mREFD,
mRCFD, and mRPD.
In this study, we used a within-subject design to avoid interjump variability. It has been suggested
that method agreement–type studies should involve at least 40 participants for adequate statistical
accuracy [25]. Despite our smaller number of participants, repeated measurements on individual
subjects (four jumps per subject) resulted in 60 cases, increasing statistical accuracy [26].
Despite the wide use of portable devices, only a few independent research studies have addressed
their reliability and validity [13,14,17,18,27]. One interesting finding of this research is the validity and
reliability of some CMJ-derived parameters (CT, EccD, ConD, PF) obtained from Myotest, possibly
of interest for fatigue-monitoring purposes. Gathercole et al. [12] reported small changes in EccD
(increase) and PF (decrease) immediately after exercise (three yo-yo intermittent endurance tests
separated by 5 min active recovery), possibly indicating good capacity of these parameters to detect
neuromuscular fatigue. Similarly, our study showed that Myotest-derived CT, EccD, ConD, and PF
can be used to track changes in neuromuscular function throughout recovery. In addition, reports
in professional soccer players have shown that fluctuations in high-intensity running (>14.4 km·h−1)
on the previous day were associated with CMJ-derived JH fluctuations [3]. However, this correlation
was small (r = 0.23), and therefore we speculate that other neuromuscular parameters may be more
sensitive for detecting neuromuscular fatigue induced by training load, rather than JH. Therefore,
future studies should employ Myotest in the field on a daily basis and analyze with CMJ-derived
variables to investigate fatigue response to training.
It should also be noted that FT, JH, F@0V, FTTPF, TTPP, and FT:CT showed good test–retest
reliability in all portable devices, but significant differences from FP measurements. This possibly
indicates that these parameters are less accurate for assessing training adaptations and monitoring
fatigue. Our results on FT and JH as CMJ performance indicators corroborates results of previous
attempts investigating the concurrent validity of Myotest in relation to FP [13] or even to Optojump
when assumed as gold standard [14]. Specifically, our study showed that JH evaluated in Myotest was
overestimated in Optojump by ~12 cm. This was also observed in previous efforts to concurrently
validate assessment of Myotest, employing indirect estimations of JH (calculated from vertical take-off
velocity) [14]. However, when employing the FT equation instead of taking CMJ data from the Myotest
display (based on take-off velocity), JH can be more accurately estimated [10]_ENREF_9. Indeed,
our results show that FT measured by Myotest is neither valid nor reliable. This could partially
be attributed to the different methodologies adopted. In the present study, different methods were
adopted using direct measurement of JH and FT (by MCAP), possibly obtaining more accurate results
than when using a portable device as the gold standard (e.g., Optojump) [14].
Although the results obtained from Ergojump showed a lack of concurrent validity in relation to
gold-standard devices (r = 0.61; [<0.90]) it accomplished the reliability assumptions (ICC = 0.54 [>0.50];
CV = 8.2 [<10%]). This is likely because the switch mat directly computes FT using the time taken from
take-off to landing. On the other hand, the system indirectly calculates JH based on flight time, possibly
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explaining observed differences (<8 cm) compared to the MCAP. Future studies may implement a
more rigorous protocol with more jump trials, which could contribute to increased reliability.
Sharing the same method of calculation, JH outcomes from Optojump and Ergojump are similar,
except for validity (r = 0.98 and 0.61, respectively). Indeed, FT obtained from Optojump was almost
perfectly correlated, reliable, and not different compared to FP. This is in accordance with Castagna et
al. [13], who observed a nearly perfect correlation (r = 0.99) and no significant differences between FT
measured in Optojump and FP. Moreover, Glatthorn et al. [16] reported a correlation coefficient of 0.99
between Optojump and FP for JH values, even if a systematic bias of ~1 cm was observed. In addition,
previous reports showed excellent test–retest reliability (ICC = 0.98, CV = 2.7%) of JH from Optojump
and low random error between repetitions (~2.8 cm) [16].
In the present study, despite large association and good reliability, FT and JH obtained from
MyJump were significantly different from gold-standard devices. JH findings are partially in agreement
with previous reports showing either significant associations (r = 0.96–0.99) or no differences between
MyJump and FP [17,28]. In this study, differences in JH between MyJump and gold-standard devices
could be attributed to the fact that the take-off and landing frame selection in MyJump was performed
manually, which could increase the measurement error. Fortunately, the continued progress of
technology indicates that in the near future smartphones will include cameras with higher recording
frequencies, which may reduce the measurement error of MyJump.
The rate of force and rate of power development indicate how rapidly force or power changes (i.e.,
rate of change) from the beginning to the end of the CMJ. Reliability statistics showed that mRCFD,
mRCED, and mRPD have larger variability than the other variables. These findings are supported by
previous research investigating the test–retest reliability of mRFD (CV = 16–35%) [20]. This inherent
variability may be explained by dynamic system theory, which suggests that movement coordination
is adjusted for perturbation to obtain a consistent performance outcome, and therefore both the rate
of force and the rate of power development during CMJ may be more reflective of coordination
adjustment than the characteristics of the lower extremities [20].
As a main limitation, the subjects differed in sports activities (e.g., weight lifting, resistance
training, and recreational team sports), possibly affecting our results. Therefore, future studies should
explore the reliability of these parameters in professional athletes.
Athletes are subject to frequent alterations to their training schedule, according to coaches’
decisions and the competitive calendar. Therefore, another important aspect of field testing is the
flexibility allowed by the coach to change assessment scheduling, without any commitment to external
laboratories. We used the standardized CMJ version (hands remained in contact with the spine of the
pelvis) to analyze test–retest reliability. Future studies may use the arm-swing CMJ version to verify
whether the jump technique affects the reliability of variables, as well as further novel systems (e.g.,
Xbox Kinect).
5. Conclusions
This study compares a wide range of CMJ-derived variables over six different devices, aiming
to analyze the most convenient tool to be employed for on-field neuromuscular testing. Although
the portable devices showed different levels of accuracy to measure CMJ according to the specific
neuromuscular parameters analyzed, Myotest should be preferred to measure CMJ-derived temporal
parameters during ground contact (e.g., CT and EccD). Ergojump, Optojump, and MyJump quantify
the time taken from jump take-off to landing and may be adopted to measure FT or JH. Optojump
seems to show the most accurate CMJ performance measurement across these devices. Finally, with
the exception of rate of force and rate of power development, all parameters analyzed in the current
study showed good capacity to detect changes irrespective of the equipment used. The application
of portable devices could be of interest for coaches and practitioners to schedule and change testing
or training sessions according to the team’s or player’s calendar, without any commitment to an
external laboratory.
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